Seoul National University Hospital: Diabetes Mellitus, Type 2 trials

The registry lists 16 Diabetes Mellitus, Type 2 studies with Seoul National University Hospital as lead sponsor. 1 are open to participants now and 1 have results posted.

Early Phase 1 1Phase 3 1Phase 4 6No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes PatientsRecruitingNCT04932928Not applicable
• Effect of Premeal Protein-bar on Glycemic Control in Patients With Type 2 DiabetesCompletedNCT03727854Not applicableResults posted
• Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With HypertriglyceridaemiaCompletedNCT04700436Phase 4
• Glimepiride, Alogliptin and Alogliptin+Pioglitazone CombinationStatus unknownNCT04470310Phase 4
• Safety of Preoperative Carbohydrate Loading in Diabetic PatientsCompletedNCT04456166
• Precision Nutrition Counseling in Type 2 Diabetes PatientsStatus unknownNCT04266171Not applicable
• The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300CompletedNCT03406663Not applicable
• Effect of Dapagliflozine on Systemic and Renal Endothelial FunctionStatus unknownNCT02501616Phase 4
• Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta CellCompletedNCT02420392Not applicable
• Patient-Centered Smartphone-Based Diabetes CareCompletedNCT02313363Early Phase 1
• Effect of Gemigliptin on Metabolic Endotoxemia and LipemiaCompletedNCT02186080Not applicable
• The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin HormonesCompletedNCT02180334Phase 4
• The Role of 1.5-anhydro-D-glucitol as Clinical Biomarkers of Hypoglycemia in Patients With DiabetesCompletedNCT02068300
• Effects of Vildagliptine and Glimepiride on Glucose VariabilityCompletedNCT01812122Phase 4
• Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With DiabetesStatus unknownNCT01185236Phase 4
• Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes MellitusCompletedNCT01037842Phase 3